Topics

bluebird bio Appoints Joanne Smith-Farrell, Ph.D., to Chief Business Officer

08:00 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
bluebird bio, Inc. (Nasdaq: BLUE), has appointed Joanne Smith-Farrell, Ph.D., to chief business officer. In this role, Joanne will lead corporate development and strategy, and she will also continue to serve as our oncology fran...

Other Sources for this Article

bluebird bio
Investors:
Elizabeth Pingpank, 617-914-8736
epingpank@bluebirdbio.com

Media:
Jenn Snyder, 617-448-0281
jsnyder@bluebirdbio.com

NEXT ARTICLE

More From BioPortfolio on "bluebird bio Appoints Joanne Smith-Farrell, Ph.D., to Chief Business Officer"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...